Transcatheter hepatocyte transplantation

Preclinical studies of anatomic consequences in the portal vascular bed

Andrew Kerr, Pankaj Rajvanshi, Sanjeev Gupta

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Rationale and Objectives: Intrasplenic transplantation deposits hepatocytes in host hepatic sinusoids with amelioration of chronic liver failure and genetic deficiency states. Because portal resistance can be altered by intrasinusoidal transplanted cells, we examined whether hepatocyte recipients would develop deleterious portal hypertension or portosystemic collaterals. Methods: Syngeneic hepatocytes in suspension were transplanted into recipient rats by transcatheter injection into the splenic parenchyma. Subjects included recipients of 2×107 hepatocytes representing approximately 3% of the host hepatic mass, recipients of 7.5×107 hepatocytes representing approximately 12.5% of the host hepatic mass, normal control rats, and positive control rats with portal hypertension induced by partial portal vein constriction. Portal pressures were recorded with a sensitive transducer, portosystemic collaterals were demonstrated with direct splenoportography, and survival of transplanted cells was determined with an endogenous dipeptidyl peptidase IV reporter gene. Results: In normal rats, the portal pressure was 6.25±1.9 mm Hg with no portosystemic collaterals. By contrast, portal pressures were significantly increased in portal vein-constricted rats, 20.7±3.9 mm Hg (P<0.001), with extensive portosystemic collaterals. In hepatocyte recipients, portal hypertension observed during transcatheter cell injection but proved transient. When animals were examine dup to 16 weeks after hepatocyte transplantation, portal pressures were in the normal range (after 2×107 cells, 7.5×2.6 mm Hg; after 7.5×107 cells, 9.5±4.2 mm Hg, P=not significant). No portosystemic collaterals developed in hepatocyte recipients at various times up to 8 months after transplantation. Transplanted hepatocytes expressing the reporter gene were present in recipients with assimilation in host hepatic cords. Conclusion: Despite injection of a massive number of cells, transcatheter hepatocyte transplantation was devoid of any significant portal vascular alterations or toxicity in recipients. These findings are consistent with assimilation of transplanted hepatocytes, into host hepatic cords and will facilitate therapeutic applications in metabolic diseases or acute liver failure.

Original languageEnglish (US)
Pages (from-to)229-236
Number of pages8
JournalAcademic Radiology
Volume1
Issue number3
DOIs
StatePublished - 1994

Fingerprint

Blood Vessels
Hepatocytes
Transplantation
Portal Pressure
Portal Hypertension
Liver
Portal Vein
Reporter Genes
Injections
Portography
Dipeptidyl Peptidase 4
End Stage Liver Disease
Acute Liver Failure
Metabolic Diseases
Transducers
Constriction
Cell Survival
Suspensions
Reference Values
Cell Count

Keywords

  • dipeptidyl peptidase
  • Hepatocyte transplantation
  • portal hypertension
  • portosystemic collaterals
  • splenoportography

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Transcatheter hepatocyte transplantation : Preclinical studies of anatomic consequences in the portal vascular bed. / Kerr, Andrew; Rajvanshi, Pankaj; Gupta, Sanjeev.

In: Academic Radiology, Vol. 1, No. 3, 1994, p. 229-236.

Research output: Contribution to journalArticle

@article{4aee202bebab4cdcb671982cfd63f726,
title = "Transcatheter hepatocyte transplantation: Preclinical studies of anatomic consequences in the portal vascular bed",
abstract = "Rationale and Objectives: Intrasplenic transplantation deposits hepatocytes in host hepatic sinusoids with amelioration of chronic liver failure and genetic deficiency states. Because portal resistance can be altered by intrasinusoidal transplanted cells, we examined whether hepatocyte recipients would develop deleterious portal hypertension or portosystemic collaterals. Methods: Syngeneic hepatocytes in suspension were transplanted into recipient rats by transcatheter injection into the splenic parenchyma. Subjects included recipients of 2×107 hepatocytes representing approximately 3{\%} of the host hepatic mass, recipients of 7.5×107 hepatocytes representing approximately 12.5{\%} of the host hepatic mass, normal control rats, and positive control rats with portal hypertension induced by partial portal vein constriction. Portal pressures were recorded with a sensitive transducer, portosystemic collaterals were demonstrated with direct splenoportography, and survival of transplanted cells was determined with an endogenous dipeptidyl peptidase IV reporter gene. Results: In normal rats, the portal pressure was 6.25±1.9 mm Hg with no portosystemic collaterals. By contrast, portal pressures were significantly increased in portal vein-constricted rats, 20.7±3.9 mm Hg (P<0.001), with extensive portosystemic collaterals. In hepatocyte recipients, portal hypertension observed during transcatheter cell injection but proved transient. When animals were examine dup to 16 weeks after hepatocyte transplantation, portal pressures were in the normal range (after 2×107 cells, 7.5×2.6 mm Hg; after 7.5×107 cells, 9.5±4.2 mm Hg, P=not significant). No portosystemic collaterals developed in hepatocyte recipients at various times up to 8 months after transplantation. Transplanted hepatocytes expressing the reporter gene were present in recipients with assimilation in host hepatic cords. Conclusion: Despite injection of a massive number of cells, transcatheter hepatocyte transplantation was devoid of any significant portal vascular alterations or toxicity in recipients. These findings are consistent with assimilation of transplanted hepatocytes, into host hepatic cords and will facilitate therapeutic applications in metabolic diseases or acute liver failure.",
keywords = "dipeptidyl peptidase, Hepatocyte transplantation, portal hypertension, portosystemic collaterals, splenoportography",
author = "Andrew Kerr and Pankaj Rajvanshi and Sanjeev Gupta",
year = "1994",
doi = "10.1016/S1076-6332(05)80720-2",
language = "English (US)",
volume = "1",
pages = "229--236",
journal = "Academic Radiology",
issn = "1076-6332",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Transcatheter hepatocyte transplantation

T2 - Preclinical studies of anatomic consequences in the portal vascular bed

AU - Kerr, Andrew

AU - Rajvanshi, Pankaj

AU - Gupta, Sanjeev

PY - 1994

Y1 - 1994

N2 - Rationale and Objectives: Intrasplenic transplantation deposits hepatocytes in host hepatic sinusoids with amelioration of chronic liver failure and genetic deficiency states. Because portal resistance can be altered by intrasinusoidal transplanted cells, we examined whether hepatocyte recipients would develop deleterious portal hypertension or portosystemic collaterals. Methods: Syngeneic hepatocytes in suspension were transplanted into recipient rats by transcatheter injection into the splenic parenchyma. Subjects included recipients of 2×107 hepatocytes representing approximately 3% of the host hepatic mass, recipients of 7.5×107 hepatocytes representing approximately 12.5% of the host hepatic mass, normal control rats, and positive control rats with portal hypertension induced by partial portal vein constriction. Portal pressures were recorded with a sensitive transducer, portosystemic collaterals were demonstrated with direct splenoportography, and survival of transplanted cells was determined with an endogenous dipeptidyl peptidase IV reporter gene. Results: In normal rats, the portal pressure was 6.25±1.9 mm Hg with no portosystemic collaterals. By contrast, portal pressures were significantly increased in portal vein-constricted rats, 20.7±3.9 mm Hg (P<0.001), with extensive portosystemic collaterals. In hepatocyte recipients, portal hypertension observed during transcatheter cell injection but proved transient. When animals were examine dup to 16 weeks after hepatocyte transplantation, portal pressures were in the normal range (after 2×107 cells, 7.5×2.6 mm Hg; after 7.5×107 cells, 9.5±4.2 mm Hg, P=not significant). No portosystemic collaterals developed in hepatocyte recipients at various times up to 8 months after transplantation. Transplanted hepatocytes expressing the reporter gene were present in recipients with assimilation in host hepatic cords. Conclusion: Despite injection of a massive number of cells, transcatheter hepatocyte transplantation was devoid of any significant portal vascular alterations or toxicity in recipients. These findings are consistent with assimilation of transplanted hepatocytes, into host hepatic cords and will facilitate therapeutic applications in metabolic diseases or acute liver failure.

AB - Rationale and Objectives: Intrasplenic transplantation deposits hepatocytes in host hepatic sinusoids with amelioration of chronic liver failure and genetic deficiency states. Because portal resistance can be altered by intrasinusoidal transplanted cells, we examined whether hepatocyte recipients would develop deleterious portal hypertension or portosystemic collaterals. Methods: Syngeneic hepatocytes in suspension were transplanted into recipient rats by transcatheter injection into the splenic parenchyma. Subjects included recipients of 2×107 hepatocytes representing approximately 3% of the host hepatic mass, recipients of 7.5×107 hepatocytes representing approximately 12.5% of the host hepatic mass, normal control rats, and positive control rats with portal hypertension induced by partial portal vein constriction. Portal pressures were recorded with a sensitive transducer, portosystemic collaterals were demonstrated with direct splenoportography, and survival of transplanted cells was determined with an endogenous dipeptidyl peptidase IV reporter gene. Results: In normal rats, the portal pressure was 6.25±1.9 mm Hg with no portosystemic collaterals. By contrast, portal pressures were significantly increased in portal vein-constricted rats, 20.7±3.9 mm Hg (P<0.001), with extensive portosystemic collaterals. In hepatocyte recipients, portal hypertension observed during transcatheter cell injection but proved transient. When animals were examine dup to 16 weeks after hepatocyte transplantation, portal pressures were in the normal range (after 2×107 cells, 7.5×2.6 mm Hg; after 7.5×107 cells, 9.5±4.2 mm Hg, P=not significant). No portosystemic collaterals developed in hepatocyte recipients at various times up to 8 months after transplantation. Transplanted hepatocytes expressing the reporter gene were present in recipients with assimilation in host hepatic cords. Conclusion: Despite injection of a massive number of cells, transcatheter hepatocyte transplantation was devoid of any significant portal vascular alterations or toxicity in recipients. These findings are consistent with assimilation of transplanted hepatocytes, into host hepatic cords and will facilitate therapeutic applications in metabolic diseases or acute liver failure.

KW - dipeptidyl peptidase

KW - Hepatocyte transplantation

KW - portal hypertension

KW - portosystemic collaterals

KW - splenoportography

UR - http://www.scopus.com/inward/record.url?scp=0028535599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028535599&partnerID=8YFLogxK

U2 - 10.1016/S1076-6332(05)80720-2

DO - 10.1016/S1076-6332(05)80720-2

M3 - Article

VL - 1

SP - 229

EP - 236

JO - Academic Radiology

JF - Academic Radiology

SN - 1076-6332

IS - 3

ER -